Ascent Industries Co.: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 8, 2023 and accepted by EDGAR at Nov 8, 2023, 17:24 ET.
Management's discussion and analysis
As filed, 31,806 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
This discussion and analysis summarizes the significant factors affecting our consolidated operating results, liquidity, and capital resources during the three and nine months ended September 30, 2023 and 2022, respectively. We intend for this discussion to provide the reader with information that will assist in understanding our financial statements, the changes in certain key items in those financial statements from year to year, and the primary factors that accounted for those changes, as well as how certain accounting principles affect our financial statements. This discussion and analysis should be read in conjunction with the consolidated financial statements and notes to the consolidated financial statements that are included in our Annual Report on Form 10-K for the year ended December 31, 2022 (the Annual Report), as well as the condensed consolidated financial statements (unaudited) and notes to the condensed consolidated financial statements (unaudited) contained in this report. Unless otherwise specified, all comparisons made are to the corresponding period of 2022. This discussion and analysis is presented in five sections:
- Executive Overview
- Results of Operations and Non-GAAP Financial Measures
- Liquidity and Capital Resources
- Material Cash Requirements from Contractual and Other Obligations
- Critical Accounting Policies and Estimates
Executive Overview
During the third quarter, we continued to experience challenges to the strategic changes we have implemented over the last several quarters, along with difficult end market conditions from macro-economic volatility including continued inflationary pressures, continued increased raw material and labor costs in both segments of our business as well as continued reduced demand resulting from inventory management measures being pursued by our customers. Despite this difficult environment, we believe we are making progress to stabilize the business and return to an acceptable level of profitability. We have continued managing working capital effectively throughout the year to generate cash and pay down debt, a decrease of $18.5 million to date in 2023. During the quarter, we also continued our efforts of creating sustainable value for our shareholders by repurchasing 44,799 shares for $0.4 million bringing our year to date total to 95,955 shares for a total of $0.9 million repurchased under our share repurchase program.
Munhall Closure
During the second quarter of 2023, the Board of Directors of the Company made the decision to permanently cease operations at Munhall effective on or around August 31, 2023. This strategic decision is part of the Company’s ongoing efforts to consolidate manufacturing to drive an increased focus on its core operations and to improve profitability while driving operational efficiencies. As a result of this decision, Munhall results have been reclassified from the Tubular Products segment and as discontinued operations in all periods presented. The discussion and analysis of our results of operations refers to continuing operations unless noted.
Goodwill Impairment Review
During the third quarter of 2023, as described in Note 7 - Goodwill, Intangible Assets and Deferred Charges, we tested our goodwill for impairment. The Company determined potential indicators of impairment within the Specialty Chemicals reporting unit, with an associated goodwill balance of $11.4 million existed. Macroeconomic conditions and pressures, increased risks within the broader specialty chemicals business, reporting unit operating losses and a decline in the reporting unit's net sales compared to forecast, collectively, indicated that the reporting unit had experienced a triggering event and the need to perform a quantitative evaluation of goodwill. The Company performed a discounted cash flow analysis and a market multiple analysis for the Specialty Chemicals reporting unit to determine the reporting unit's fair value. The discounted cash flow analysis included management assumptions for expected sales growth, capital expenditures and overall operational forecasts while the market multiple analysis included historical and projected performance, market capitalization, volatility and multiples for industry peers. Determining the fair value of the reporting unit and allocation of that fair value to individual assets and liabilities within the reporting unit to determine the implied fair value of the goodwill is judgmental in nature and requires the use of significant management estimates and assumptions. Any changes in the judgments, estimates, or assumptions could produce significantly different results. As a result of the goodwill impairment evaluation, it was concluded that the estimated fair value of the Specialty Chemicals reporting unit was below its carrying value by 27.6% resulting in a goodwill impairment charge of $11.4 million for the three and nine months ended September 30, 2023.
Macroeconomic Events
In February 2022, the United States announced targeted economic sanctions on Russia in response to the military conflict in Ukraine. As our operations are located in North America, we have no direct exposure to Russia and Ukraine. However, we are actively monitoring the broader economic impact of the crisis, especially the potential impact on commodity and fuel prices, and the potential decreased demand for our products.
There are additional macroeconomic uncertainties, including continued global supply chain constraints, labor shortages and the continuing impact of inflation, which continues to impact the Company's raw material costs. The Company continues efforts to implement price increases, as appropriate, to offset these inflationary pressures and continues to take action to drive working capital efficiencies and evaluate other opportunities to maintain and improve financial performance in the short and long term.
Results of Operations
Consolidated Performance Summary
Consolidated net sales for the third quarter of 2023 were $56.1 million, a decrease of $22.1 million, or 28.3%, compared to net sales for the third quarter of 2022. The decrease in net sales was primarily driven by a 23.2% decrease in pounds shipped and a 6.4% decrease in average selling prices.
Consolidated net sales for the first nine months of 2023 were $184.2 million, a decrease of $62.3 million, or 25.3%, compared to net sales for the first nine months of 2022. The decrease in net sales was primarily driven by a 21.5% decrease in pounds shipped and a 3.8% decrease in average selling prices.
For the third quarter of 2023, consolidated gross profit decreased 57.3% to $6.0 million, or 10.7% of sales, compared to $14.1 million, or 18.0% of sales in the third quarter of 2022. For the first nine months of 2023, consolidated gross profit decreased 70.6% to $16.4 million, or 8.9% of sales, compared to $55.7 million, or 22.6% of sales for the first nine months of 2022. The decrease was attributable to the decrease in volumes as well as continued increasing raw material and labor costs in 2023.
Consolidated selling, general, and administrative expense (SG&A) for the third quarter of 2023 decreased $1.9 million to $7.4 million, or 13.1% of sales, compared to $9.3 million, or 11.8% of sales in the third quarter of 2022. The decrease in SG&A expense for the third quarter of 2023 was primarily driven by decreases in incentive bonus, amortization expense and salaries, wages and benefits, partially offset by increases in professional fees and bad debt expense.
Consolidated SG&A expense for the first nine months of 2023 decreased $2.8 million to $22.6 million, or 12.3% of sales, compared to $25.4 million, or 10.3% of sales for the first nine months of 2022. The decrease in SG&A expense for the first nine months of 2023 was primarily driven by decreases in incentive bonus, amortization expense, salaries wages and benefits, bad debt expense, travel expense and stock based compensations expense partially offset by increases in professional fees.
Consolidated operating loss in the third quarter of 2023 totaled $12.8 million compared to operating income of $4.7 million in the third quarter of 2022. The operating decrease in the third quarter of 2023 was primarily driven by the aforementioned goodwill impairment within the Company's Specialty Chemicals segment and decrease in gross profit partially offset by decreases in SG&A costs.
Consolidated operating loss in the first nine months of 2023 totaled $17.9 million compared to operating income of $29.5 million in the first nine months of 2022. The operating decrease in the first nine months of 2023 was primarily driven by the aforementioned goodwill impairment within the Company's Specialty Chemicals segment and decrease in gross profit partially offset by decreases in SG&A costs.
Tubular Products
On January 1, 2023, the Company changed the grouping of certain immaterial revenue and expenses associated with the ceased Palmer operations. As a result, certain prior period Tubular Products segment results have been reclassified to be comparable to the current period's presentation.
Net sales in the third quarter of 2023 totaled $36.1 million, a decrease of $14.5 million, or 28.7%, from the third quarter of 2022. The decrease was primarily driven by a 19.7% decrease in pounds shipped and a 10.9% decrease in average selling prices.
Net sales in the first nine months of 2023 totaled $119.0 million, a decrease of $43.1 million, or 26.6%, from the first nine months of 2022. The decrease was primarily driven by a 21.8% decrease in pounds shipped and a 5.5% decrease in average selling prices.
The net sales decrease for the third quarter of 2023 compared to the third quarter of 2022 is summarized as follows:
($ in thousands)
| $% | Average selling price | Units shipped | ||
|---|---|---|---|---|
| Heavy wall seamless carbon steel pipe and tube | (2,918) | (23.8)% | (9.0)% | (16.2)% |
| Stainless steel pipe and tube | (11,627) | (30.3)% | (11.1)% | (21.6)% |
| Total decrease | $(14,545) |
The net sales decrease for the first nine months of 2023 compared to the first nine months of 2022 is summarized as follows:
($ in thousands)
| $% | Average selling price | Units shipped | ||
|---|---|---|---|---|
| Heavy wall seamless carbon steel pipe and tube | (4,730) | (12.9)% | 3.5% | (15.8)% |
| Stainless steel pipe and tube | (38,346) | (30.6)% | (7.0)% | (25.4)% |
| Total decrease | $(43,076) |
SG&A expense for the third quarter of 2023 decreased to $2.5 million compared to $3.2 million in the third quarter of 2022. As a percentage of sales, SG&A expense increased to 7.0% of sales in the third quarter of 2023 compared to 6.3% of sales in the third quarter of 2022. The changes in SG&A were primarily driven by decreases in amortization expense and salaries, wages and benefits compared to prior year, partially offset by increase in bad debt expense.
SG&A expense for the first nine months of 2023 decreased to $7.9 million compared to $10.0 million in the first nine months of 2022. As a percentage of sales, SG&A expense increased to 6.6% of sales in the first nine months of 2023 compared to 6.2% of sales in the first nine months of 2022. The changes in SG&A were primarily driven by decreases in amortization expense, salaries, wages and benefits, travel and incentive bonus expense in the current year compared to the prior year.
Operating income decreased to $1.7 million for the third quarter of 2023 compared to operating income of $7.6 million for the third quarter of 2022. Operating income decreased to $3.3 million for the first nine months of 2023 compared to operating income of $34.8 million for the first nine months of 2022. Current year decrease in operating income was primarily driven by the aforementioned decrease in net sales and continued increases in material and labor costs partially offset by decreases in SG&A expense.
Specialty Chemicals
Net sales in the third quarter of 2023 totaled $20.1 million, representing a $7.3 million, or 26.6%, decrease from the third quarter of 2022. The decrease was driven by a 24.8% decrease in pounds shipped as well as a 2.7% decrease in average selling prices.
Net sales in the first nine months of 2023 totaled $65.2 million, representing a $18.9 million, or 22.5%, decrease from the first nine months of 2022. The decrease was driven by a 21.0% decrease in pounds shipped partially offset by a 0.3% increase in average selling prices.
SG&A expense for the third quarter of 2023 decreased to $2.0 million, or 9.8% of sales, compared to $2.3 million, or 8.3% of sales in the third quarter of 2022. The decrease was primarily driven by decreases in incentive bonus and amortization expense partially offset by increases in professional fees and salaries, wages and benefits.
SG&A expense for the first nine months of 2023 decreased to $5.3 million, or 8.1% of sales, compared to $5.4 million, or 6.5% of sales in the first nine months of 2022. The increase was primarily driven by decreases in amortization expense and incentive bonus partially offset by increases in professional fees and salaries, wages and benefits
Operating loss increased to $11.5 million for the third quarter of 2023 compared to operating income of $1.1 million for the third quarter of 2022. Current year increase in operating loss was primarily driven by the aforementioned goodwill impairment charge of $11.4 million and the decrease in net sales.
Operating loss increased to $10.9 million for the first nine months of 2023 compared to operating income of $6.1 million for the first nine months of 2022. Current year increase in operating loss was primarily driven by the aforementioned goodwill impairment charge of $11.4 million and the decrease in net sales.
Corporate & Other Items
Unallocated corporate and other expenses for the third quarter of 2023 decreased $1.2 million, or 28.6%, to $3.0 million, or 5.3% of sales, compared to $4.2 million, or 5.4% of sales, in the prior year. The third quarter of 2023 decrease was primarily driven by decreases in incentive bonus, salaries, wages and benefits and other corporate overhead, partially offset by increases in professional fees, taxes and licenses and insurance expense.
Unallocated corporate and other expenses for the first nine months of 2023 decreased $1.0 million, or 8.4%, to $10.0 million, or 5.5% of sales, compared to $11.0 million, or 4.5% of sales, in the prior year. The first nine months of 2023 decrease was primarily driven by decrease in incentive bonus, salaries, wages and benefits, stock compensation and other corporate overhead costs, partially offset by increases in professional fees, taxes and licenses and insurance expense.
Interest expense for the third quarter of 2023 increased to $1.1 million, from $0.8 million for the third quarter of 2022. Interest expense for the first nine month of 2023 increased to $3.2 million, from $1.6 million for the first nine month of 2022. The increase is primarily driven by higher interest rates in the current year compared to the prior year.
The effective tax rate was 7.0% and 11.2% for the three and nine months ended September 30, 2023. The September 30, 2023 effective tax rate was lower than the U.S. statutory rate of 21.0% primarily due to the effects of permanent goodwill impairment reducing the tax benefit in the period.
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States ("GAAP"), we use the following non-GAAP financial measures: EBITDA and Adjusted EBITDA. Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.
EBITDA and Adjusted EBITDA
We define "EBITDA" as earnings before interest (including change in fair value of interest rate swap), income taxes, depreciation and amortization. We define "Adjusted EBITDA" as EBITDA further adjusted for the impact of non-cash and other items we do not consider in our evaluation of ongoing performance. These items include: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, shelf registration costs, loss on extinguishment of debt, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, retention costs and restructuring and severance costs from net income. We caution investors that amounts presented in accordance with our definitions of EBITDA and Adjusted EBITDA may not be comparable to similar measures disclosed by other companies because not all companies calculate EBITDA and Adjusted EBITDA in the same manner. We present EBITDA and Adjusted EBITDA because we consider them to be important supplemental measures of our performance and investors' understanding of our performance is enhanced by including these non-GAAP financial measures as a reasonable basis for comparing our ongoing results of operations.
Consolidated EBITDA and Adjusted EBITDA from continuing operations are as follows:
($ in thousands)
| Consolidated | Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 |
|---|---|---|---|---|
| Net income (loss) from continuing operations | $(12,769) | $3,105 | $(18,466) | $23,934 |
| Adjustments: | ||||
| Interest expense | 1,063 | 827 | 3,217 | 1,637 |
| Income taxes | (964) | 871 | (2,350) | 4,069 |
| Depreciation | 1,590 | 1,748 | 4,833 | 4,950 |
| Amortization | 376 | 1,098 | 1,129 | 2,440 |
| EBITDA | (10,704) | 7,649 | (11,637) | 37,030 |
| Acquisition costs and other | 42 | 149 | 323 | 836 |
| Goodwill impairment | 11,389 | — | 11,389 | — |
| Gain on lease modification | — | — | — | (2) |
| Stock-based compensation | 142 | 307 | 389 | 697 |
| Non-cash lease expense | 69 | 109 | 205 | 323 |
| Retention expense | 6 | — | 6 | — |
| Restructuring and severance cost | — | — | 103 | 10 |
| Adjusted EBITDA | $944 | $8,214 | $778 | $38,894 |
| % of sales | 1.7% | 10.5% | 0.4% | 15.8% |
Tubular Products EBITDA and Adjusted EBITDA from continuing operations are as follows:
($ in thousands)
| Tubular Products | Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 |
|---|---|---|---|---|
| Net income from continuing operations | $1,705 | $7,640 | $3,265 | $34,760 |
| Adjustments: | ||||
| Depreciation | 626 | 637 | 1,916 | 2,000 |
| Amortization | 217 | 576 | 653 | 1,728 |
| EBITDA | 2,548 | 8,853 | 5,834 | 38,488 |
| Acquisition costs and other | 42 | — | 46 | — |
| Stock-based compensation | 11 | 34 | 2 | 53 |
| Non-cash lease expense | 36 | — | 109 | (1) |
| Restructuring and severance costs | — | — | 97 | — |
| Tubular Products Adjusted EBITDA | $2,637 | $8,887 | $6,088 | $38,540 |
| % of segment sales | 7.3% | 17.6% | 5.1% | 23.8% |
27
Specialty Chemicals EBITDA and Adjusted EBITDA are as follows:
($ in thousands)
| Specialty Chemicals | Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 |
|---|---|---|---|---|
| Net income (loss) | $(11,498) | $1,088 | $(10,974) | $6,083 |
| Adjustments: | ||||
| Interest expense | 21 | 9 | 52 | 28 |
| Depreciation | 942 | 1,097 | 2,850 | 2,897 |
| Amortization | 159 | 520 | 475 | 712 |
| EBITDA | (10,376) | 2,714 | (7,597) | 9,720 |
| Acquisition costs and other | — | — | 2 | — |
| Goodwill impairment | 11,389 | — | 11,389 | — |
| Stock-based compensation | 3 | 12 | (13) | 29 |
| Non-cash lease expense | 23 | — | 69 | 1 |
| Specialty Chemicals Adjusted EBITDA | $1,039 | $2,726 | $3,850 | $9,750 |
| % of segment sales | 5.2% | 10.0% | 5.9% | 11.6% |
Liquidity and Capital Resources
We closely manage our liquidity and capital resources. Our liquidity requirements depend on key variables, including level of investment required to support our business strategies, the performance of our business, capital expenditures, credit facilities and working capital management. Capital expenditures and share repurchases are a component of our cash flow and capital management strategy which we can adjust in response to economic and other changes in our business environment. We have a disciplined approach to capital allocation focusing on priorities that support our business and growth.
Sources of Liquidity
Funds generated by operating activities supplemented by our available cash and cash equivalents and our credit facilities are our most significant sources of liquidity. As of September 30, 2023, we held $0.7 million of cash and cash equivalents, as well as $41.8 million of remaining available capacity on our revolving line of credit. We believe our sources of liquidity will be sufficient to fund operations and anticipated capital expenditures as well as repay our debt obligations as they become due over the next 12 months and beyond.
Cash Flows
Cash flows from continuing operations were as follows:
(in thousands)
| Total cash provided by (used in): | Nine Months Ended September 30, 2023 | 2022 |
|---|---|---|
| Operating activities | $4,132 | $5,672 |
| Investing activities | (2,660) | (2,870) |
| Financing activities | (19,433) | 1,788 |
| Net increase (decrease) in cash and cash equivalents | $(17,961) | $4,590 |
Operating Activities
The decrease in cash provided by operating activities for the nine months ended September 30, 2023, compared to cash provided by operating activities in the nine months ended September 30, 2022, was primarily driven by the decrease in earnings in the current year partially offset changes in working capital. Changes in working capital can vary significantly depending on factors such as the timing of inventory production and purchases, customer payments of accounts receivable and payments to vendors in the regular course of business. Inventory increased operating cash flows for the first nine months of
2023 by $0.5 million compared to a decrease of $30.3 million for the first nine months of 2022, while accounts payable increased operating cash flows by $5.9 million for the first nine months of 2023, compared to $10.2 million in the first nine months of 2022. The decrease in inventory and accounts payable is primarily driven by lower inventory purchases to match inventory levels with sales partially and slightly higher inventory turns year-over-year offset by decrease in days payables outstanding. Accounts receivable increased operating cash flows by $3.8 million in the first nine months of 2023 compared to a $6.2 million decrease in the first nine months of 2022. The increase in cash generated by accounts receivable is primarily driven by a decrease in days sales outstanding compared to the first nine months of 2022.
Investing Activities
Net cash used in investing activities primarily consists of transactions related to capital expenditures. The decrease in cash used in investing activities for the nine months ended September 30, 2023, compared to the cash used in investing activities for the nine months ended September 30, 2022, was primarily due to decreases in capital expenditures in the current year compared to the prior year.
Financing Activities
Net cash used in financing activities primarily consists of transactions related to our long-term debt. The increase in cash used in financing activities for the nine months ended September 30, 2023, compared to cash used in financing activities for the nine months ended September 30, 2022, was primarily due to decreased borrowings and increased repayments under the Company's credit facility compared to the prior year.
Short-term Debt
The Company has a note payable in the amount of $0.9 million with an annual interest rate of 3.70% maturing April 1, 2024, associated with the financing of the Company's insurance premium in the current year. As of September 30, 2023, the outstanding balance was $0.6 million.
Long-term Debt
The Company and its subsidiaries have a Credit Agreement with BMO providing the Company with a four-year revolving credit facility, maturing on January 15, 2025, and providing the Company with up to $150.0 million of borrowing capacity. As of September 30, 2023, the Company had $53.0 million of total borrowings outstanding with its lender, a decrease of $18.5 million from the balance at December 31, 2022. The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $7.5 million and (ii) 10% of the revolving credit facility (currently $10.5 million). As of September 30, 2023, the Company was in compliance with all financial debt covenants. See Note 8 in the notes to the unaudited condensed consolidated financial statements for additional information on the Company's line of credit.
Share Repurchases and Dividends
We have a share repurchase program, authorized by the Company's Board of Directors, that is executed through purchases made from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions. Shares repurchased are returned to status of authorized, but unissued shares of common stock or held in treasury.
Shares repurchased for the three and nine months ended September 30, 2023 and 2022 were as follows:
| Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|---|---|
| Number of shares repurchased | 44,799 | 30 | 95,955 | 30 |
| Average price per share | $8.87 | $16.29 | $9.38 | $16.59 |
| Total cost of shares repurchased | $398,861 | $493 | $903,012 | $493 |
As of September 30, 2023, the Company has 584,024 shares of its share repurchase authorization remaining.
At the end of each fiscal year the Board of Directors reviews the financial performance and capital needed to support future growth to determine the amount of cash dividend, if any, which is appropriate. In 2022, no dividends were declared or paid by the Company.
Other Financial Measures
Below are additional financial measures that we believe are important in understanding the Company's liquidity position from year to year. The metrics are defined as:
Liquidity Measure:
- Current ratio = current assets divided by current liabilities. The current ratio will be determined by the Company using generally accepted accounting principles, consistently applied.
Leverage Measure:
- Debt to capital = total debt divided by total capital. The debt to capital ratio will be determined by the Company using generally accepted accounting principles, consistently applied.
Profitability Ratio:
- Return on average equity ("ROAE") = net income divided by the trailing 12-month average of equity. The ROAE will be determined by the Company using generally accepted accounting principles, consistently applied.
Results of these additional measures are as follows:
| September 30, 2023 | December 31, 2022 | |
|---|---|---|
| Current ratio | 3.7 | 4.4 |
| Debt to capital | 35% | 44% |
| Return on average equity | (20.8)% | 33.7% |
Material Cash Requirements from Contractual and Other Obligations
As of September 30, 2023, our material cash requirements for our known contractual and other obligations were as follows:
- Debt Obligations and Interest Payments - Outstanding obligations on our revolving credit facility and term loan were $49.4 million and $3.6 million, respectively, with $2.5 million payable within 12 months. The interest payments on our remaining borrowings will be determined based upon the average outstanding balance of our borrowings and the prevailing interest rate during that time. Outstanding obligations on our note payable were $0.6 million, which matures within 12 months. Interest payments on the remaining note payable borrowings will be based on an interest rate of 3.70%. See Note 8 for further detail of our debt and the timing of expected future payments.
- Operating and Finance Leases - The Company enters into various lease agreements for the real estate and manufacturing equipment used in the normal course of business. Operating and finance lease obligations were $32.9 million, with $1.4 million payable within 12 months. See Note 9 for further detail of our lease obligations and the timing of expected future payments.
The Company has no off-balance sheet arrangements that are reasonably likely to have a material current or future effect on the Company's financial position, revenues, results of operations, liquidity, or capital expenditures. We expect capital spending to be as much as $1.0 million for the remainder of fiscal 2023.
Critical Accounting Policies and Estimates
We describe our significant accounting policies in Note 1, Summary of Significant Accounting Policies, in the notes to the consolidated financial statements presented in the Annual Report on Form 10-K for the year ended December 31, 2022. We discuss our critical accounting estimates in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, in the Annual Report on Form 10-K for the year ended December 31, 2022. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of fiscal 2022, except as discussed below.
Assets Held for Sale
We classify long-lived assets or disposal groups as held for sale in the period when all of the following conditions have been met:
- the Board of Directors have approved and committed to a plan to sell the assets or disposal group;
- the asset or disposal group is available for immediate sale in its present condition;
- an active program to locate a buyer and other actions required to complete the sale have been initiated;
- the sale of the asset or disposal group is probable and expected to be completed within one year;
- the asset or disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and,
- it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.
We initially measure a long-lived asset or disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell and recognize any loss in the period in which the held for sale criteria are met. Gains are not recognized until the date of sale. We cease depreciation and amortization of a long-lived asset, or assets within a disposal group, upon their designation as held for sale and subsequently assess fair value less any costs to sell at each reporting period until the asset or disposal group is no longer classified as held for sale.
Market risk
As filed, 161 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
We are a smaller reporting company as defined in Rule 12b-2 of the Exchange Act; therefore, we are not required to provide the information required by this Item.
Controls and procedures
As filed, 6,196 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
The term “disclosure controls and procedures” is defined in Rule 13a-15(e) of the Exchange Act as “controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the SEC rules and forms.” The Company’s disclosure controls and procedures are designed to ensure that material information relating to the Company and its consolidated subsidiaries is accumulated and communicated to its management, including its Chief Executive Officer and its Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosures. The Company’s management, with the participation of its Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of September 30, 2023. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2023, because of the previously reported material weaknesses in internal control over financial reporting, as described below.
Previously Reported Material Weaknesses in Internal Control over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15f-15(f). As reported in our 2022 Form 10-K, we did not maintain effective internal control over financial reporting as of December 31, 2022 as a result of material weaknesses in the control environment and control activities areas. A material weakness (as defined in Rule 12b-2 under the Exchange Act) is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Refer to our 2022 Form 10-K for a description of our material weaknesses.
Ongoing Remediation Efforts to Address Material Weaknesses
Our material weaknesses were not remediated at September 30, 2023. Our Board of Directors and management are committed to the continued implementation of remediation efforts to address the material weaknesses. The Company has a remediation plan which includes designing and implementing review and approval controls over the data utilized in various accounting processes, controls that will address the accuracy, timely recording and completeness of data used in the determination of significant accounting estimates, reserves and valuations in accordance with U.S. GAAP, controls that will address the sufficient review of complex accounting areas and controls that will address the monitoring of general information technology areas including user access, cyber security and segregation of duties.
The following steps are among the measures being taken by the Company with a number of these initiatives directly related to strengthening our controls and addressing specific control deficiencies which contributed to the material weaknesses. The steps to remediate the deficiencies underlying the material weaknesses include:
- Hiring adequate accounting, finance and information technology resources to enhance the capabilities of these functions across the organization.
- Providing and expanding relevant training on internal controls over financial reporting to control owners and control preparers across the organization to reinforce the importance of a strong control environment
- Evaluating and realigning roles and responsibilities of management
- Evaluating and realigning roles and responsibilities of control owners and control preparers to maintain segregation of duties
- Developing enhanced policies and procedures relating to documentation of control activities performed including those that reflect the control attributes performed and the demonstration of completeness and accuracy of the data used in the control.
- Enhancing/designing/implementing controls over the inventory, revenue recognition and accounts receivable, period-end financial reporting, account analyses, and journal entry processes
- Enhancing/designing/implementing controls over accounting for complex areas
- Enhancing/designing/implementing controls over general information technology controls, including user access provisioning and cyber-security
The Audit Committee of the Board of Directors is monitoring management's ongoing remediation efforts. With the Audit Committee's oversight, management has dedicated significant resources and efforts to improve our internal control environment to remedy the identified material weaknesses. As we continue to evaluate and implement improvements to our internal control over financial reporting, our management may decide to take additional measures to address our control deficiencies or to modify the remediation efforts undertaken. Because the reliability of the internal control process requires repeatable execution, our material weaknesses cannot be considered fully remediated until all remedial processes and procedures (including additional remediation efforts identified by our senior management as necessary) have been implemented, each applicable control has operated for a sufficient period of time and management has concluded, through testing, that the controls are operating effectively. Until all identified material weaknesses are remediated, we will not be able to assert that our internal controls are effective.
Changes in Internal Control over Financial Reporting
Other than the ongoing remediation efforts described above, there have been no changes in the Company’s internal control over financial reporting during the three and nine months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.
Risk factors
As filed, 178 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no material changes in our assessment of risk factors as discussed in Part I, Item 1A in the Company's Annual Report on Form 10-K for the year ended December 31, 2022.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $56.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $184.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-07-01 to 2023-09-30 | $50.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-01-01 to 2023-09-30 | $167.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-07-01 to 2023-09-30 | $6.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-01-01 to 2023-09-30 | $16.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-07-01 to 2023-09-30 | $7.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-01-01 to 2023-09-30 | $22.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-07-01 to 2023-09-30 | −$12.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-01-01 to 2023-09-30 | −$17.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-07-01 to 2023-09-30 | $1.1m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-01-01 to 2023-09-30 | $3.2m | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-01 to 2023-09-30 | −$964.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | −$2.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | −$17.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | −$37.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-01 to 2023-09-30 | −$1.77 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-01 to 2023-09-30 | −$3.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-01 to 2023-09-30 | −$1.77 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-01 to 2023-09-30 | −$3.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 10,135,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 10,151,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $21.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-01 to 2023-09-30 | $2.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-01-01 to 2023-09-30 | $903.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-30 | $730.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $135.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $215.2m | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $36.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $118.9m | us-gaap:Liabilities |
| Long-term debt | At period end2023-09-30 | $50.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-09-30 | $2.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-09-30 | $96.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000095953-23-000055. Last ingested by Listed: Nov 4, 2026, 19:10 ET. Listed shows no prices and gives no investment advice.